{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:31:33Z","timestamp":1786555893827,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.therap.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:34:17Z","timestamp":1757140457000},"page":"346-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progressive outer retinal necrosis complicating aseptic meningitis due to varicella zoster virus reactivation 44 days after infusion of natalizumab"],"prefix":"10.1016","volume":"81","author":[{"given":"Hidaya","family":"Drissi Oudghiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ferreira De Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahim","family":"Azzouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Brodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-5071","authenticated-orcid":false,"given":"Yohan","family":"N\u2019Guyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.09.001_bib0065","doi-asserted-by":"crossref","first-page":"omab035","DOI":"10.1093\/omcr\/omab035","article-title":"Varicella-zoster virus aseptic meningitis: an atypical presentation in an immunocompetent male patient","volume":"2021","author":"Platanaki","year":"2021","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.therap.2025.09.001_bib0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09273948.2012.710705","article-title":"Progressive outer retinal necrosis presenting as cherry red spot","volume":"20","author":"Yiu","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.therap.2025.09.001_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12886-017-0655-4","article-title":"Atypical acute retinal necrosis accompanied by Terson's syndrome: a case report","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.therap.2025.09.001_bib0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"St\u00fcve","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.therap.2025.09.001_bib0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12886-021-02096-x","article-title":"Acute retinal necrosis caused by co-infection with multiple viruses in a natalizumab-treated patient: a case report and brief review of literature","volume":"21","author":"Cheraqpour","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.therap.2025.09.001_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40262-018-0680-3","article-title":"Influence of antigen mass on the pharmacokinetics of therapeutic antibodies in humans","volume":"58","author":"Ternant","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.therap.2025.09.001_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2025.09.001_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2025.09.001_bib0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2025.09.001_bib0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","article-title":"Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function","volume":"72","author":"Khatri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.therap.2025.09.001_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ICB.0000000000000136","article-title":"Acute retinal necrosis and immune reconstitution inflammatory syndrome in a natalizumab-treated patient with multiple sclerosis","volume":"9","author":"Saraiva","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.therap.2025.09.001_bib0120","doi-asserted-by":"crossref","first-page":"102838","DOI":"10.1016\/j.msard.2021.102838","article-title":"Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients","volume":"50","author":"van Kempen","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:36:30Z","timestamp":1786552590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595725001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0040595725001076"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.09.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive outer retinal necrosis complicating aseptic meningitis due to varicella zoster virus reactivation 44 days after infusion of natalizumab","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}